Tobam’s United Therapeutics Corp Del Position
Does Tobam own United Therapeutics Corp Del (UTHR)? Yes — 8.9K shares worth $5M (+1.38% of its 13F portfolio) as of Q1 2026, up from 7.6K shares the prior filed quarter.
Position Value
$5M
Q1 2026
Shares
8.9K
% of Portfolio
+1.38%
Quarters Held
16
currently held
Position History UTHR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 8.9K | $5M | +1.38% |
| Q3 2025 | 7.6K | $3M | +1.16% |
| Q2 2025 | 2.7K | $774,000 | +0.30% |
| Q1 2025 | 6.4K | $2M | +0.84% |
| Q4 2024 | 18.2K | $6M | +1.96% |
| Q3 2024 | 37.9K | $14M | +2.48% |
| Q2 2024 | 56.3K | $18M | +2.81% |
| Q1 2024 | 108.6K | $25M | +2.24% |
| Q4 2023 | 113.8K | $25M | +2.19% |
| Q3 2023 | 145.4K | $33M | +2.64% |
| Q2 2023 | 148.5K | $33M | +2.47% |
| Q1 2023 | 169.9K | $38M | +2.51% |
| Q4 2022 | 109.3K | $30M | +2.01% |
| Q3 2022 | 41.5K | $9M | +0.61% |
| Q2 2022 | 3.8K | $888,000 | +0.06% |
| Q4 2018 | 17.1K | $2M | +0.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tobam’s full portfolio or all institutional holders of UTHR.